比较临床衰弱量表和国际疾病分类第10版改良衰弱指数在预测危重症患者长期生存中的作用
Comparing the Clinical Frailty Scale and an International Classification of Diseases-10 Modified Frailty Index in Predicting Long-Term Survival in Critically Ill Patients.
作者信息
Subramaniam Ashwin, Ueno Ryo, Tiruvoipati Ravindranath, Darvall Jai, Srikanth Velandai, Bailey Michael, Pilcher David, Bellomo Rinaldo
机构信息
Department of Intensive Care, Peninsula Health, Frankston, VIC, Australia.
Division of Medicine, Peninsula Clinical School, Monash University, Frankston, VIC, Australia.
出版信息
Crit Care Explor. 2022 Oct 13;4(10):e0777. doi: 10.1097/CCE.0000000000000777. eCollection 2022 Oct.
UNLABELLED
The Clinical Frailty Scale (CFS) is the most used frailty measure in intensive care unit (ICU) patients. Recently, the modified frailty index (mFI), derived from 11 comorbidities has also been used. It is unclear to what degree the mFI is a true measure of frailty rather than comorbidity. Furthermore, the mFI cannot be freely obtained outside of specific proprietary databases.
OBJECTIVE
To compare the performance of CFS and a recently developed International Classification of Diseases-10 (ICD-10) mFI (ICD-10mFI) as frailty-based predictors of long-term survival for up to 1 year.
DESIGN
A retrospective multicentric observational study.
SETTING AND PARTICIPANTS
All adult (≥16 yr) critically ill patients with documented CFS scores admitted to sixteen Australian ICUs in the state of Victoria between April 1, 2017 to June 30, 2018 were included. We used probabilistic methods to match de-identified ICU admission episodes listed in the Australia and New Zealand Intensive Care Society Adult Patient Database with the Victorian Admission Episode Dataset and the Victorian Death Index via the Victorian Data Linkage Centre.
MAIN OUTCOMES AND MEASURES
The primary outcome was the longest available survival following ICU admission. We compared CFS and ICD-10mFI as primary outcome predictors, after adjusting for key confounders.
RESULTS
The CFS and ICD-10mFI were compared in 7,001 ICU patients. The proportion of patients categorized as frail was greater with the CFS than with the ICD-10mFI (18.9% [ = 1,323] vs. 8.8% [ = 616]; < 0.001). The median (IQR) follow-up time was 165 (82-276) days. The CFS predicted long-term survival up to 6 months after adjusting for confounders (hazard ratio [HR] = 1.26, 95% CI, 1.21-1.31), whereas ICD-10mFI did not (HR = 1.04, 95% CI, 0.98-1.10). The ICD-10mFI weakly correlated with the CFS (Spearman's rho = 0.22) but had a poor agreement (kappa = 0.06). The ICD-10mFI more strongly correlated with the Charlson comorbidity index (Spearman's rho 0.30) than CFS (Spearman's rho = 0.25) ( < 0.001).
CONCLUSIONS
CFS, but not ICD-10mFI, predicted long-term survival in ICU patients. ICD-10mFI correlated with co-morbidities more than CFS. These findings suggest that CFS and ICD-10mFI are not equivalent.
RELEVANCE
CFS and ICD-10mFI are not equivalent in screening for frailty in critically ill patients and therefore ICD-10mFI in its current form should not be used.
未标注
临床衰弱量表(CFS)是重症监护病房(ICU)患者中使用最广泛的衰弱评估工具。最近,源自11种合并症的改良衰弱指数(mFI)也被应用。目前尚不清楚mFI在多大程度上是真正的衰弱指标而非合并症指标。此外,除了特定的专有数据库外,无法免费获取mFI。
目的
比较CFS和最近开发的基于国际疾病分类第十版(ICD - 10)的mFI(ICD - 10mFI)作为长达1年的长期生存的衰弱预测指标的性能。
设计
一项回顾性多中心观察性研究。
设置与参与者
纳入2017年4月1日至2018年6月30日期间在维多利亚州16家澳大利亚ICU住院且有记录CFS评分的所有成年(≥16岁)重症患者。我们使用概率方法,通过维多利亚数据链接中心,将澳大利亚和新西兰重症监护学会成人患者数据库中列出的匿名ICU入院记录与维多利亚入院记录数据集和维多利亚死亡指数进行匹配。
主要结局与测量指标
主要结局是ICU入院后的最长可获得生存时间。在调整关键混杂因素后,我们比较了CFS和ICD - 10mFI作为主要结局预测指标的情况。
结果
对7001例ICU患者的CFS和ICD - 10mFI进行了比较。被归类为衰弱的患者比例,CFS高于ICD - 10mFI(18.9% [n = 1323] 对8.8% [n = 616];P < 0.001)。中位(IQR)随访时间为165(82 - 276)天。调整混杂因素后,CFS可预测长达6个月的长期生存(风险比[HR] = 1.26,95%可信区间,1.21 - 1.3),而ICD - 10mFI则不能(HR = 1.04,95%可信区间,0.98 - 1.1)。ICD - 10mFI与CFS弱相关(斯皮尔曼等级相关系数rho = 0.22),但一致性较差(kappa = 0.06)。ICD - 10mFI与查尔森合并症指数的相关性(斯皮尔曼等级相关系数rho 0.30)强于与CFS的相关性(斯皮尔曼等级相关系数rho = 0.25)(P < 0.001)。
结论
CFS而非ICD - 10mFI可预测ICU患者的长期生存。ICD - 10mFI与合并症的相关性强于CFS。这些发现表明CFS和ICD - 10mFI并不等同。
相关性
CFS和ICD - 10mFI在重症患者衰弱筛查中并不等同,因此目前形式的ICD - 10mFI不应被使用。
相似文献
Crit Care Explor. 2022-5-25
Chronic Obstr Pulm Dis. 2024-1-25
引用本文的文献
J Am Geriatr Soc. 2025-8
Adv Exp Med Biol. 2024
Crit Care Resusc. 2024-6-28
本文引用的文献
Age Ageing. 2021-6-28
Ann Intensive Care. 2021-2-3
Anesth Analg. 2020-6
Acta Anaesthesiol Scand. 2020-1